Latest 10-K annual reports
NYSE
BRC
Brady CORPBrady Corporation announced robust fiscal year 2026 results, driven by organic sales growth and strategic acquisitions, culminating in the significant PSS business acquisition.
NASDAQ
Cisco Systems, Inc. (CSCO) announced its fiscal year 2026 results, showcasing a 12% increase in total revenue to $63.3 billion, driven by robust demand in networking solutions, particularly AI infrastructure.
NASDAQ
Provident Financial Holdings, Inc. filed its annual report for the fiscal year ended June 30, 2026, detailing steady net income growth, a strong capital position, and strategic focus on community banking.
OTC.Pink
NEXT-ChemX Corporation has filed an amended annual report for fiscal year 2024, detailing ongoing financial struggles, a significant net loss, and the impact of auditor changes, while highlighting the development of its iTDE technology.
NASDAQ
RGS
Regis CORPRegis Corporation's Form 10-K for fiscal year 2026 details a year of strategic integration following the Alline acquisition, with mixed results across its franchise and company-owned salon segments.
NASDAQ
BMRA
Biomerica INCBiomerica, Inc. filed its annual report for the fiscal year ended May 31, 2026, detailing a 16% revenue decline, continued operating losses, and significant concerns regarding its ability to continue as a going concern, though it secured additional financing and advanced product commercialization.
OQB
Stimcell Energetics Inc. reported a significant increase in net loss and operating expenses for the fiscal year ended May 31, 2026, while continuing to generate no revenue, highlighting ongoing financial challenges and a substantial working capital deficit.
NASDAQ
Super Micro Computer, Inc. reported a significant surge in revenue for fiscal year 2026, driven by robust demand for its AI and data center solutions, though gross margins saw a slight contraction.
Regenerex Pharma, Inc. reported a significant net loss for the nine months ended December 31, 2025, and faces substantial doubt about its ability to continue as a going concern, despite strategic initiatives in wound care.
OQB
CYDY
Cytodyn INCCytoDyn Inc. filed its annual report detailing ongoing clinical development of leronlimab, but highlighting significant financial challenges, including a going concern warning from auditors and substantial operating losses.
NASDAQ
NCRA
Nocera, INCNocera, Inc. has filed an amended 2025 annual report detailing significant net losses, ongoing going concern issues, and a revenue decline, while also outlining new financing and strategic investments.
NASDAQ
Jack Henry & Associates, Inc. (JKHY) filed its annual report, detailing a 7.1% revenue increase to $2.54 billion and a 10.3% rise in net income to $502.8 million for fiscal year 2026.
NASDAQ
Anavex Life Sciences Corp. files an amendment to its annual report, disclosing a material weakness in internal controls and restating its financial reporting opinion.
NASDAQ
Strattec Security Corporation's annual report details a 3% increase in net sales to $579.4 million and a 150 basis point expansion in gross margin to 16.5%, driven by pricing and volume, alongside a 10% rise in net income.
NASDAQ
IBIO
Ibio, INCiBio, Inc. reports progress in its AI-driven antibody development for obesity and cardiometabolic diseases, with its IBIO-600 entering Phase 1 trials and securing substantial funding.
NASDAQ
LTRX
Lantronix INCLantronix, Inc. filed its annual report for the fiscal year ended June 30, 2026, detailing a slight revenue decrease but highlighting growth in Embedded IoT Solutions and Software & Services.
NASDAQ
Affirm Holdings, Inc. (AFRM) filed its annual report, showcasing a 37% increase in Gross Merchandise Volume (GMV) to $50.2 billion for the fiscal year ended June 30, 2026, alongside a significant tax benefit that resulted in a substantial net income.
NASDAQ
LFVN
Lifevantage CORPLifeVantage Corporation's annual report for fiscal year 2026 indicates a substantial decrease in net revenue and active accounts, primarily driven by lower sales across key product lines.
NASDAQ
ARAY
Accuray INCAccuray Incorporated's Form 10-K for the fiscal year ended June 30, 2026, details a significant net loss, increased debt, and ongoing material weaknesses in financial reporting, alongside a strategic financing transaction.
Hyperliquid Strategies Inc. has filed its annual report, detailing its digital asset treasury strategy focused on HYPE tokens, including significant unrealized gains and staking operations.
OTC.Pink
Tech Tonic Group Corp. filed its annual report for the fiscal year ended June 30, 2026, detailing a decrease in revenue, a net loss, and significant concerns regarding its ability to continue as a going concern.
NASDAQ
Malibu Boats, Inc. (MBUU) filed its annual report for the fiscal year ended June 30, 2026, detailing a 13.3% increase in net sales to $914.6 million, largely attributed to the acquisition of Saxdor Yachts Oy.
NASDAQ
Aviat Networks, Inc. has updated its Insider Trading Policy Statement to provide guidance to its officers, directors, employees, consultants, and other related individuals regarding transactions in the Company's securities.
Lucky Strike Entertainment Corporation's annual report details a 4% revenue increase to $1.245 billion, offset by a net loss of $35.8 million and rising interest expenses.
NASDAQ
QNST
Quinstreet, INCQuinStreet, Inc. announced robust financial results for fiscal year 2026, with net revenue increasing by 18% and net income soaring to $81.2 million.
NYSE
SLQT
Selectquote, INCSelectQuote, Inc. files its annual report, detailing its capital stock structure, anti-takeover provisions, and corporate governance, alongside financial performance and risk factors.
NASDAQ
The Marzetti Company announced record net sales of $1.93 billion for fiscal year 2026, a 1.1% increase driven by strategic pricing and the acquisition of Bachans, with operating income rising 8.3%.
NASDAQ
Gulf Resources Inc. reported a significant 75% year-over-year revenue decline for fiscal year 2024, alongside substantial net losses and ongoing challenges with Nasdaq listing requirements.
NASDAQ
TECH
Bio-techne CORPBio-Techne Corporation has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, for $73.00 per share in cash, with an expected closing by late 2026 or early 2027.
NASDAQ
Napco Security Technologies, Inc. announced its fiscal year 2026 results, showcasing an 11.4% increase in total revenue to $202.3 million, driven by robust equipment and recurring service revenue growth.